Cellectis Company

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
Technology: CAR-T
Industry: CAR-T
Headquarters: Paris, Ile-de-France, France
Founded Date: 1999-12-01
Employees Number: 51-100
Funding Status: IPO
Acquisitions Number: 2
Investors Number: 5
Total Funding: 276000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-04-11
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership